Swiss Parliament Rejects Proposal to Ban Tobacco Advertisements

Regulations by 2FIRSTS.ai
Mar.05.2024
Swiss Parliament Rejects Proposal to Ban Tobacco Advertisements
Swiss Parliament rejects proposal to ban tobacco and e-cigarette ads, sparking debate among political parties. Future uncertain.

According to persoenlich report, the Swiss parliament rejected the proposal for a ban on tobacco advertising aimed at children and adolescents, with a vote of 121 to 64 (5 abstentions). The proposal sought to completely ban the advertising of tobacco products and e-cigarettes, and had received majority support from voters in a national referendum in February 2022.

 

Currently, the proposal is set to be sent back to the Senate. If the Senate rejects it again or if the House of Representatives opposes it a second time, the proposal will come to an end. At that point, Parliament will need to come up with a new plan to implement the new constitutional provisions.

 

According to reports, there is a clear division among political parties regarding the vote on the proposal. The Swiss People's Party (SVP) criticizes the Federal Council's draft for exceeding the scope of the original proposal, believing that the law would be unenforceable and unreasonable in practice. On the other hand, the Social Democrats (SP) and the Green Party are trying to push for strict enforcement of the proposal to achieve a complete ban on tobacco advertising. They argue that the current parliamentary decision ignores the will of the people.

 

In such a division, the proposal ultimately faced rejection in the legislature.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated
Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated
Luxembourg’s Chamber of Deputies adopted Bill No. 8333, transposing EU Directive 2022/2100 and extending tobacco controls to heated tobacco, e-cigarettes and nicotine pouches. The law bans flavourings, restricts sales to minors, and caps nicotine content at 0.048 mg per pouch. CBD and caffeine additives are prohibited.
Nov.03 by 2FIRSTS.ai
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
FASTA has launched a new disposable, the FASTA ALIEN 51K, on U.S. online channels. Retailer Mi-Pod describes the product as “assembled and filled in the U.S.” and labels it as compliant with Texas e-cigarette registration requirements. The ALIEN 51K is now available via Mi-Pod and Vaping, with a suggested retail price of about $19.99.
Nov.12 by 2FIRSTS.ai
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York Attorney General Letitia James has filed a petition seeking to permanently shut down two smoke shops and ban their owners from the vape industry for repeatedly selling illegal flavored vapes to minors and operating without valid licenses. The nearly 50-page complaint names Eysa Sharhan and Ahmed Mozeb and their stores — Pop-In Smoke & Vape LLC, Pufftopia LLC, and Royalty Tobacco LLC — accusing them of a “persistent pattern of illegal activity.”
Oct.24 by 2FIRSTS.ai
China’s E-Cigarette Exports Reached USD 879 Million in September 2025, Down 6.08% MoM— U.S. Remains Top Market, Russia Falls Sharply
China’s E-Cigarette Exports Reached USD 879 Million in September 2025, Down 6.08% MoM— U.S. Remains Top Market, Russia Falls Sharply
In September 2025, China’s total e-cigarette exports reached USD 879 million, representing a 6.08% decline month-on-month but a 3.41% increase year-on-year.
Oct.20 by 2FIRSTS.ai
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.
Nov.14
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21